InvestorsHub Logo
Followers 1
Posts 154
Boards Moderated 0
Alias Born 01/30/2012

Re: None

Friday, 11/22/2013 12:25:05 PM

Friday, November 22, 2013 12:25:05 PM

Post# of 1313
$12,000 in available cash as per the last 10Q. Potential for crash & burn is very high. Burned through the $200k grant and now running on fumes.

Correvio earned $30million+ per year for global sales of aggrastat...not a serious contender. And they got bought out by a company with a market cap around $70 million.

Hope the annual shareholder meeting (11/26) goes well, if any shareholders show up. Have to vote on their accountants compensation. By the way, bankrupt Savient Pharmaceuticals shares a similar market valuation with Medicure.

Bring on another reverse split.